Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates ... Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. Mehr anzeigen
Recent successful meeting with the FDA provides path to file for accelerated approval and subsequent conversion to full approvalPlan to submit biologics license application (BLA) early in 2025...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.65 | 2.24292615597 | 28.98 | 33.33 | 28.2276 | 868340 | 30.30188492 | CS |
| 4 | 2.43 | 8.93382352941 | 27.2 | 33.33 | 25.55 | 699077 | 28.07899218 | CS |
| 12 | 5.79 | 24.2869127517 | 23.84 | 33.33 | 23.41 | 840740 | 27.89116082 | CS |
| 26 | 11.16 | 60.4223064429 | 18.47 | 33.33 | 17.93 | 969793 | 24.259042 | CS |
| 52 | 13.71 | 86.1180904523 | 15.92 | 33.33 | 14.56 | 1058729 | 21.38533485 | CS |
| 156 | -21.56 | -42.117601094 | 51.19 | 51.3948 | 14.56 | 806354 | 25.65642523 | CS |
| 260 | 14.75 | 99.126344086 | 14.88 | 93.94 | 12.39 | 718666 | 32.18984652 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
